Jeng-yuan Hsu

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Correction: Cheng et al. NICEFIT-A Prospective, Non-Interventional, and Multicentric Study for the Management of Idiopathic Pulmonary Fibrosis with Antifibrotic Therapy in Taiwan. Biomedicines 2022, 10, 2362.

Correction: Cheng et al. NICEFIT-A Prospective, Non-Interventional, and Multicentric Study for the Management of Idiopathic Pulmonary Fibrosis with Antifibrotic Therapy in Taiwan. Biomedicines 2022, 10, 2362.

Journal: Biomedicines

Published: January 09, 2025

Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study.

Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study.

Journal: Biomedicines

Published: August 16, 2024

Functional sequence variants of intergenic long noncoding RNA on chromosome 17q21 are associated with asthma.

Functional sequence variants of intergenic long noncoding RNA on chromosome 17q21 are associated with asthma.

Journal: The European respiratory journal

Published: June 18, 2024

BTEX exposure and its body burden pose differential risks for asthma and its phenotypic clusters.

BTEX exposure and its body burden pose differential risks for asthma and its phenotypic clusters.

Journal: Allergy

Published: January 16, 2023

The Effectiveness and Tolerability of Glycopyrronium for Patients with Chronic Obstructive Pulmonary Disease in a Clinical Setting: GLARE-Taiwan.

The Effectiveness and Tolerability of Glycopyrronium for Patients with Chronic Obstructive Pulmonary Disease in a Clinical Setting: GLARE-Taiwan.

Journal: Journal of clinical medicine

Published: October 02, 2022

NICEFIT-A Prospective, Non-Interventional, and Multicentric Study for the Management of Idiopathic Pulmonary Fibrosis with Antifibrotic Therapy in Taiwan.

NICEFIT-A Prospective, Non-Interventional, and Multicentric Study for the Management of Idiopathic Pulmonary Fibrosis with Antifibrotic Therapy in Taiwan.

Journal: Biomedicines

Published: June 13, 2022

Relationship between exposure to ozone and exacerbation requiring hospital admission among patients with asthma: a case-control study in central Taiwan.

Relationship between exposure to ozone and exacerbation requiring hospital admission among patients with asthma: a case-control study in central Taiwan.

Journal: BMJ open

Published: February 15, 2022

Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study.

Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study.

Journal: Thorax

Published: October 22, 2021

Predictors of a Minimal Clinically Important Difference Following Omalizumab Treatment in Adult Patients With Severe Allergic Asthma.

Predictors of a Minimal Clinically Important Difference Following Omalizumab Treatment in Adult Patients With Severe Allergic Asthma.

Journal: Frontiers in medicine

Published: August 21, 2021

The Long-Term Effectiveness of Omalizumab in Adult Patients with Severe Allergic Asthma: Continuous Treatment Versus Boosting Treatment.

The Long-Term Effectiveness of Omalizumab in Adult Patients with Severe Allergic Asthma: Continuous Treatment Versus Boosting Treatment.

Journal: Journal of clinical medicine

Published: January 09, 2021

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study.

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study.

Journal: Drug design, development and therapy

Published: June 10, 2020

The prevalence and clinical features of chronic obstructive pulmonary disease patients with traits of asthma in Taiwan.

The prevalence and clinical features of chronic obstructive pulmonary disease patients with traits of asthma in Taiwan.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: June 02, 2020

Showing 1-12 of 44

Last Updated: 09/26/2026